|Bid||15.10 x 0|
|Ask||15.17 x 0|
|Day's Range||14.65 - 16.64|
|52 Week Range||8.62 - 24.75|
|Beta (3Y Monthly)||3.96|
|PE Ratio (TTM)||84.17|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.56|
Marijuana companies in Canada have been pouring cash into their businesses to both fend off competition and open stores as the list of medical and recreational approvals for marijuana use globally grows. In the reported quarter, Canopy's operating expenses rose more than six times to C$180.6 million from C$27.7 million a year earlier. Canopy has the money after drawing a multi-billion dollar investment from Corona beer maker Constellation Brands in August, a reflection of investors betting broader legalization in the United States may also be in the pipeline.
CORAL GABLES, FL / ACCESSWIRE / November 8, 2018 / Marijuana stocks have seen a surge of attention this year. This event has been well received by the public markets as many marijuana stocks have positively reacted to this news. Sessions, who has been a staunch adversary of the legalization of cannabis, took a very conservative approach when broaching the subject.
Toronto, Burlington, Ontario--(Newsfile Corp. - November 5, 2018) - ACME Resources Corp. ("ACME") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) have signed a definitive agreement granting Aphria exclusive preferred global vendor status for the production and sales of RDT's QuickStrip™ technology for both medicinal and adult-use cannabis markets around the world. RDT's game-changing, proprietary QuickStrip™ technology is a Quick, ...
CORAL GABLES, FL / ACCESSWIRE / November 2, 2018 / The recent boom for things like medical marijuana in the UK as well as the rise of healthcare technology have investors interested in new and exciting companies. Recent developments across both sectors have new companies targeting expanded market share. Technology has become a major part of the healthcare industry, as we know it.
Marijuana stocks, such as Aphria Inc. (TSX:APH), are under threat from supply shortages and regulatory hurdles.
LEAMINGTON, ON, Nov. 1, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") has been granted a Manufacture Licence by the Australian Government's Office of Drug Control. The license provides Althea with authorization to manufacture extracts and tinctures of cannabis and cannabis resin in accordance with relevant manufacture permits. "We are excited to see our Australian partner achieve yet another milestone in receiving its Manufacture License.
Shopify Inc (TSX:SHOP)(NYSE:SHOP) saw its share price take a big hit last year after a biased report sent investors into a panic.
NEW YORK, NY / ACCESSWIRE / November 1, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...
Canopy Growth Corp. (TSX:WEED)(NYSE:CGC), Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB), and Aphria Inc. (TSX:APH) are all still trading in bubble territory. Investors had best be patient and wait for the right time to invest; it will come.
Leading up to the October 17th "legalization date" in Canada, investors saw a surge in cannabis stock interest. Canadian producers and retailers have been unable to keep up with the demand among consumers for cannabis products. With this in mind, we look at 3 marijuana stocks to watch as legalization continues to reach across North America.
LEAMINGTON, ON, Oct. 30, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH) and (US OTC: APHQF) announced today that its common shares have been approved for listing on the New York Stock Exchange ("NYSE") and will commence trading effective the open of markets on November 2, 2018.
Aphria Inc (TSX:APH) released its earnings earlier in the month, and there were some warning flags that investors may have missed.
Aphria Inc. (TSX:APH) and other cannabis stocks will be exposed to volatility as the industry struggles to meet soaring demand.
Aphria Inc (TSX:APH) is about to list its shares on the New York Stock Exchange. Will it be enough to rescue the stock from the cannabis sell-off?
Debt-rating agency DBRS Ltd. believes many of the cannabis producers will fail. It’s one of three reasons Aphria Inc. (TSX:APH) ought to find a partner.
LEAMINGTON, ON, Oct. 25, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today officially introduced Dr. Jonathan Simone, PhD as the Company's Director of Research and Clinical Studies. Dr. Simone joined Aphria in July 2018 and serves as the primary liaison between the Company's science, technical and medical division teams and outside medical, academic and clinical centers.
CORAL GABLES, FL / ACCESSWIRE / October 25, 2018 / According to a new report by Grand View Research, Inc., the global legal marijuana market is expected to reach $146.4 billion by end of 2025. This week the market along with several cannabis stocks are looking to turn a corner and head back toward previous highs. Integrated Cannabis Company (ICNAF) (ICAN.CN) reported today that the marijuana company has agreed to license Cannabidiol-formulated gummies.
Investorideas.com, a global news source covering leading sectors including both cannabis and solar stocks, issues a snapshot looking at how solar energy has and will play a key role in the future of the cannabis sector. Companies mentioned: Aurora Cannabis Inc. (TSX: ACB.TO) (NYSE: ACB), Solar Integrated Roofing Corporation (OTC: SIRC), Canadian Solar Inc. (NASDAQ: CSIQ), Aphria Inc. (TSX: APH.TO), (OTC: APHQF), and Emerald Health Therapeutics, Inc.